Previous Close
$1.78
Day Range
$0 - $0
Previous Day Range
$1.7 - $1.78
Market Cap
$253.3 million USD
Day Vol.
0
Previous Day Vol.
123677
Currency
USD
Primary Exchange
Nasdaq
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also ...
Community
- 0 posts discussing
0
Watchers
0
Visitors
Recent News
Trending Tickers
Please sign in to view